ESLA

Estrella Immunopharma Inc.

NASDAQ: ESLA · HEALTHCARE · BIOTECHNOLOGY

$1.20

-3.57% today

Updated 2026-06-02

Market cap

$40.88M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.34

Dividend yield

—

52W range

$1 – $3

Volume

0.1M

Market cap

$40.88M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.34

Dividend yield

—

52W range

$1 – $3

Volume

0.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

3.5

Quality

3.0

Profitability

5.0

Valuation

C+

1/9

Piotroski F-Score

Weak

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →199 stocks currently score above 75

Price targets

Analyst target

$12.00

+900.00%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths

Insufficient data

Risks

- Piotroski 1/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-6.70M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	—	$0.00	$0.00
Net income	$-996104.00	$-7.31M	$-8.85M	$-13.06M	$-2.29M
EPS	—	—	—	—	$-0.34
Free cash flow	$-1.04M	$-16.07M	$-7.64M	$-1.79M	$-6.70M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
ESLA	$40.88M	18	4.3	3.0	5.0	3.5	—	Avoid
LLY	$1.01T	76	10.0	10.0	4.3	6.0	—	Strong Buy
JNJ	$567.28B	57	4.7	9.0	3.3	6.0	-67.79%	Buy
ABBV	$391.50B	63	4.0	8.0	4.0	5.0	-48.06%	Buy
UNH	$373.28B	54	5.3	5.5	4.0	5.5	-26.94%	Buy
NVS	$289.19B	49	3.3	9.0	3.3	4.5	-65.15%	Hold

Smart narrative

Estrella Immunopharma Inc. trades at $1.20. Our Smart Value Score of 18/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score.

Frequently asked questions

What is Estrella Immunopharma Inc.'s stock price?

Estrella Immunopharma Inc. (ESLA) trades at $1.20.

Is Estrella Immunopharma Inc. overvalued?

Estrella Immunopharma Inc. carries a Smart Value Score of 18/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Estrella Immunopharma Inc. (ESLA)?

The 12-month analyst consensus target is $12.00, about 900.0% above the current $1.20. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-268.50%

Beta0.85

50D MA$1.36

200D MA$1.44

Shares out0.04B

Float0.01B

Short ratio—

Avg volume0.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

ESLA vs LLY →ESLA vs JNJ →ESLA vs ABBV →Stock screener →